Oxaev 150 Tablet SR contains Oxcarbazepine 150 mg, an antiepileptic agent primarily indicated for the treatment of partial seizures with or without secondary generalization in adults and children. Oxcarbazepine acts by stabilizing hyperexcited neural membranes, inhibiting repetitive neuronal firing, and reducing the propagation of synaptic impulses, thereby exerting its anticonvulsant effect. The sustained-release formulation ensures a gradual release of the active ingredient, maintaining steady plasma concentrations and improving patient compliance by reducing dosing frequency. Oxaev 150 Tablet SR is also utilized off-label for managing bipolar disorder and neuropathic pain, although its primary indication remains seizure control. The medication should be administered under medical supervision, with dose adjustments based on clinical response and tolerability. Common adverse effects include dizziness, somnolence, headache, nausea, and hyponatremia, necessitating periodic monitoring of serum sodium levels during therapy. Caution is advised in patients with hepatic or renal impairment, and potential drug interactions should be evaluated prior to initiation. Oxaev 150 Tablet SR should not be abruptly discontinued to avoid precipitating seizure recurrence. This medication is contraindicated in patients with hypersensitivity to Oxcarbazepine or related compounds. Proper adherence to prescribed dosing and regular follow-up are essential for optimal therapeutic outcomes.